Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11039202 | 0.86 | ALDH1A1 (0.62) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL4661575 | 0.85 | ALDH1A1 (0.57) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL4688815 | 0.84 | KMT2A (0.60) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL27770727 | 0.84 | KMT2A (0.60) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL6129940 | 0.82 | KMT2A (0.58) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL31337846 | 0.82 | ALDH1A1 (0.59) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL6830855 | 0.82 | KMT2A (0.58) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL6983963 | 0.82 | KMT2A (0.58) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL15256939 | 0.82 | ALDH1A1 (0.59) | KMT2AHTTALDH1A1TSHRMEN1 | |
| SCHEMBL859237 | 0.82 | NPC1 (0.61) | KMT2AHTTALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3400090-B1 | CATALYST COMPOSITIONS AND AMMOXIDATION PROCESSES | ASCEND PERFORMANCE MAT OPERATIONS LLC (US) | 2020-11-18 | — | — | EP | claimed |
| EP-2233476-B1 | Preparation of an ether of 2,5-(hydroxymethyl)furfural (HMF) from a fructose source, an alcohol solvent and an acid catalyst | ARCHER DANIELS MIDLAND CO (US) | 2013-08-28 | — | — | EP | claimed |
| CN-101809010-B | Hydroxymethylfurfural ethers from sugars or HMF and mixed alcohols | FURANIX TECHNOLOGIES BV | 2013-01-16 | — | — | CN | claimed |
| CN-101809010-A | hydroxymethylfurfural ethers from sugars or hmf and mixed alcohols | FURANIX TECHNOLOGIES BV | 2010-08-18 | — | — | CN | claimed |
| CN-101400666-A | Synthesis method and application of 5-alkoxymethylfurfural ether | AVANTIUM INT BV (NL) | 2009-04-01 | — | — | CN | claimed |
| CN-119013263-A | Cooling process for producing ACFC with purified increased crystal size | 伊士曼化工公司 | 2024-11-22 | — | — | CN | disclosed |
| EP-3810584-A1 | AN OXIDATION PROCESS TO PRODUCE 5-(ALKOXYCARBONYL)FURAN-2-CARBOXYLIC ACIDS(ACFC) | Eastman Chemical Company (US) | 2021-04-28 | — | — | EP | disclosed |
| CN-110191923-A | Bituminous composition comprising the humin obtained from the dehydration of carbohydrate | 阿凡田知识中心有限公司 | 2019-08-30 | — | — | CN | disclosed |
| CN-105801528-B | With metal catalyst reduction HMF ether | 阿彻丹尼尔斯米德兰德公司 | 2019-06-21 | — | — | CN | disclosed |
| US-10316011-B2 | Process for the production of 2, 5-furandicarboxylic acid (FDCA) | ANNIKKI GMBH (AT) | 2019-06-11 | — | — | US | disclosed |
| CN-109867642-A | A kind of method that boehmite efficient catalytic cellulose prepares 5 hydroxymethyl furfural | 盐城工学院 | 2019-06-11 | — | — | CN | disclosed |
| US-20180362486-A1 | PROCESS FOR THE PRODUCTION OF 2, 5-FURANDICARBOXYLIC ACID (FDCA) | Novolana GmbH (AT) | 2018-12-20 | — | — | US | disclosed |
| US-20120196335-A1 | LIGF-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-02 | — | — | US | disclosed |
| CN-101400666-B | Synthesis method and application of 5-alkoxymethylfurfural ether | AVANTIUM INT BV | 2012-07-11 | — | — | CN | disclosed |
| WO-2012036884-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| CN-102161918-A | Use of 5-alkoxymethylfurfural ethers | FURANIX TECHNOLOGIES BV | 2011-08-24 | — | — | CN | disclosed |
| CN-101809010-A | hydroxymethylfurfural ethers from sugars or hmf and mixed alcohols | FURANIX TECHNOLOGIES BV | 2010-08-18 | — | — | CN | disclosed |
| EP-2033958-A1 | Hydroxymethylfurfural ethers from sugars and di- and triols | Furanix Technologies B.V (NL) | 2009-03-11 | — | — | EP | disclosed |
| EP-1292585-A1 | BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS | Takeda Chemical Industries, Ltd. (JP) | 2003-03-19 | — | — | EP | disclosed |
| WO-2001098282-A1 | BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 2001-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180362486-A1 | PROCESS FOR THE PRODUCTION OF 2, 5-FURANDICARBOXYLIC ACID (FDCA) | HPD, FDPS, FDFT1 | KMT2A 1330/4885HTT 1532/4885ALDH1A1 204/4885 |
| US-10316011-B2 | Process for the production of 2, 5-furandicarboxylic acid (FDCA) | HPD, FDPS, FDFT1 | KMT2A 1330/4885HTT 1532/4885ALDH1A1 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.